**Core Concept**
Familial hypercholesterolemia is a genetic disorder characterized by impaired clearance of low-density lipoprotein (LDL) from the bloodstream due to defects in LDL receptor function, leading to markedly elevated plasma LDL cholesterol levels.

**Why the Correct Answer is Right**
In familial hypercholesterolemia, mutations in the LDL receptor gene result in reduced or absent LDL receptor expression on hepatocytes. This receptor is essential for endocytosing LDL particles from the blood, and its deficiency causes LDL to accumulate in the circulation. Without functional LDL receptors, cholesterol delivery to tissues is impaired, and plasma LDL levels rise dramatically, increasing cardiovascular risk.

**Why Each Wrong Option is Incorrect**
Option B: Apoprotein A is the main structural component of high-density lipoprotein (HDL), involved in reverse cholesterol transport. Its deficiency does not cause hypercholesterolemia and is associated with diseases like apolipoprotein A-I deficiency, not familial hypercholesterolemia.
Option C: Apo protein C is a cofactor for lipoprotein lipase and plays a role in triglyceride metabolism; its deficiency affects lipid clearance but is linked to hypertriglyceridemia, not elevated LDL.
Option D: Lipoprotein lipase hydrolyzes triglycerides in lipoproteins, primarily in adipose and muscle tissue. Its deficiency causes hypertriglyceridemia, not hypercholesterolemia.

**Clinical Pearl / High-Yield Fact**
Patients with familial hypercholesterolemia present with xanthomas (fatty deposits) on tendons or skin and early atherosclerosis. The hallmark is elevated LDL cholesterol and a family history of premature cardiovascular disease. Genetic testing for LDL receptor mutations confirms diagnosis.

✓ Correct Answer: A. LDL receptor